ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings for October, November

September 24, 1976

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999